Potential role of PC-1 expression and pyrophosphate elaboration in the molecular etiology of the FGFR- associated craniosynostosis syndromes

Orthodontics and Craniofacial Research

Volumn 10, Issue 2, 2007, Pages 53-58

  Hatch, Nan E ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Craniosynostosis; Fibroblast growth factor; Mineralization; Osteoblast; PC 1; Pyrophosphate

Indexed keywords

ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIREFLY LUCIFERASE; INORGANIC PYROPHOSPHATASE; PHOSPHODIESTERASE; PYROPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; BONE MINERALIZATION; CELL STRAIN 3T3; CRANIOFACIAL SYNOSTOSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; OSTEOBLAST; PHYSIOLOGY; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; UPREGULATION;

3T3 CELLS; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CRANIOSYNOSTOSES; DIPHOSPHATES; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; LUCIFERASES, FIREFLY; MICE; OSTEOBLASTS; PHOSPHORIC DIESTER HYDROLASES; PROMOTER REGIONS (GENETICS); PYROPHOSPHATASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 34547117605     PISSN: 16016335     EISSN: 16016343     Source Type: Journal    
DOI: 10.1111/j.1601-6343.2007.00387.x     Document Type: Article

References (32)

1. De Moerlooze L, Dickson C. Skeletal disorders associated with fibroblast growth factor receptor mutations. Curr Opin Genet Dev 1997;7:378-85.
2. Ornitz DM, Marie PJ. FGF Signaling in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002;16:1446-65.
3. Marie PJ. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003;316:23-32.
4. DePollack C, Renier D, Hott M, Marie P. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Min Res 1996;11:401-7.
5. Lomri A, Lemonnier J, Hott M, Perseval N, Lajeunie E, Munnich A et al. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Investig 1998;101:1310-7.
6. Fragale A, Tartaglia M, Bernardini S, Michela de Stasio AM, di Rocco C, Velardi F et al. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Path 1999;154:1465-77.
7. Rice D, Kim H, Thesleff I. Apoptosis in murine calvarial bone and suture development. Eur J Oral Sci 1999;107:265-75.
8. Dry GM, Yasinskaya YI, Williams JK, Ehrlich GD, Preston RA, Hu FZ et al. Inhibition of apoptosis: a potential mechanism for syndromic craniosynostosis. Plas Reconstr Surg 1999;107:425-32.
9. Lemmonier J, Delannoy P, Hott M, Lomri A, Modrowski D, Marie PJ. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp Cell Res 2002;256:158-67.
10. Lemonnier J, Hay E, Delannoy P, Fromigue O, Lomri A, Modrowski D et al. Increased osteoblast apoptosis in Apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Path 2001;158:1833-42.
11. Mansukhani A, Bellosta P, Sahni M, Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Bio 2000;149: 1297-308.
12. Register TC, Wuthier RE. The effect of pyrophosphate and two diphosphonates on 45Ca and 32Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite. Bone 1985;6:307-12.
13. Anderson HC, Sipe JB, Hessle L, Dhamyamraju R. Atti E. Camacho NP et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Path 2004;164:841-7.
14. Terkeltaub R, Rosenbach M, Fong F, Goding J. Causal link between nucleotide pyrophosphohydrolase over activity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glyoprotein-1. Arthrit Rheum 1994;37:934-41.
15. Fleisch H, Straumann F, Schenk R, Bisaz S, Allgower M. Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture. Am J Physiol 1966;211:821-5.
16. Johnson K, Moffa A, Chen Y, Prizker K, Goding J, Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Min Res 1999;14:883-92.
17. Johnson KA, Hessle L, Vaingankar S, Wennerg C, Mauro S, Narisawa S et al. Osteoblast tissue-nonspecific alkaline phosphatase antagonizs and regulates PC-1. Am J Physiol Int Comp Physiol 2000;279:1365-77.
18. Johnson K, Goding J, Van Etten D, Sali A, Hu S, Farley D et al. Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Min Res 2003;18:994-1004.
19. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Nat Acad Sci 2002;99:9445-9.
20. Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M et al. Mutations in ANKH cause chondrocalcinosis. Am J Hum Gen 2002;71:933-40.
21. Reichenberger E, Tiziani V, Watanabe S, Park L, Ueki Y, Santanne C et al. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Gen 2001;68:1321-6.
22. Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H et al. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Gen 2001;28:37-41.
23. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000;289: 265-70.
24. Sohn P, Crowley M, Slattery E, Serra R. Developmental and TGF-b mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthr Cart 2002;10:482-90.
25. Hatch NE, Nociti F, Swanson E, Bothwell M, Somerman M. FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK, TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4). Conn Tiss Res 2005;46:184-92.
26. Sudo H, Kodama H, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Bio 1983;96: 191-8.
27. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach P, Franceschi R. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Min Res 1999;14:893-903.
28. Kreiborg S. Crouzon syndrome: a clinical and roentgencephalometric study. Scan J Plast Reconstr Surg, 1981;18 (Suppl.):1-198.
29. Chen L, Li D, Li C, Engel A, Deng CX. A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 2003;33:169-78.
30. Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P. A gain of function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Nat Acad Sci 2004;101:12555-60.
31. Johnson K, Hashimoto S, Lotz M, Pritzker K, Goding J, Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathgenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 2001;44:1071-81.
32. Johnson K, Terkeltaub R. Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess. Osteoarthr Cart 2004;12:321-35.